Your browser doesn't support javascript.
loading
Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.
Teot, Lisa A; Schneider, Michaela; Thorner, Aaron R; Tian, Jing; Chi, Yueh-Yun; Ducar, Matthew; Lin, Ling; Wlodarski, Marcin; Grier, Holcombe E; Fletcher, Christopher D M; van Hummelen, Paul; Skapek, Stephen X; Hawkins, Douglas S; Wagers, Amy J; Rodriguez-Galindo, Carlos; Hettmer, Simone.
Affiliation
  • Teot LA; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts.
  • Schneider M; Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Germany.
  • Thorner AR; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tian J; Department of Biostatistics, University of Florida, Gainesville, Florida.
  • Chi YY; Department of Biostatistics, University of Florida, Gainesville, Florida.
  • Ducar M; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lin L; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wlodarski M; Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Germany.
  • Grier HE; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
  • Fletcher CDM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • van Hummelen P; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Skapek SX; Division of Hematology/Oncology, Children's Medical Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Hawkins DS; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, Washington.
  • Wagers AJ; Fred Hutchinson Cancer Center, Seattle, Washington.
  • Rodriguez-Galindo C; Harvard Stem Cell Institute, Cambridge, Massachusetts.
  • Hettmer S; Department of Stem Cell and Regenerative Biology, Joslin Diabetes Center, Boston, Massachusetts.
Cancer ; 124(9): 1973-1981, 2018 05 01.
Article in En | MEDLINE | ID: mdl-29461635
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Urogenital Neoplasms / Ras Proteins / Head and Neck Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Cancer Year: 2018 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Urogenital Neoplasms / Ras Proteins / Head and Neck Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Cancer Year: 2018 Document type: Article